SG142127A1 - Vapor fraction from seeds of glycine max (l.) merr. and composition thereof - Google Patents

Vapor fraction from seeds of glycine max (l.) merr. and composition thereof

Info

Publication number
SG142127A1
SG142127A1 SG200306386-4A SG2003063864A SG142127A1 SG 142127 A1 SG142127 A1 SG 142127A1 SG 2003063864 A SG2003063864 A SG 2003063864A SG 142127 A1 SG142127 A1 SG 142127A1
Authority
SG
Singapore
Prior art keywords
vapor fraction
merr
seeds
glycine max
composition
Prior art date
Application number
SG200306386-4A
Inventor
Chu I-Hung
Original Assignee
Chu I Hung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chu I Hung filed Critical Chu I Hung
Priority to SG200306386-4A priority Critical patent/SG142127A1/en
Publication of SG142127A1 publication Critical patent/SG142127A1/en

Links

Landscapes

  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

VAPOR FRACTION FROM SEEDS OF GLYCINE MAX (L.) MERR. AND COMPOSITION THEREOF The present invention mainly relates to a vapor fraction from seeds of Glycine max (L.) Merr. prepared by vaporizing a rude extract, and pharmaceutical composition thereof. The present invention also provides the use of the vapor fraction in treating skin injuries, dermatological disorders, stimulating cell regeneration, and stimulating hair growth.
SG200306386-4A 2003-09-12 2003-09-12 Vapor fraction from seeds of glycine max (l.) merr. and composition thereof SG142127A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG200306386-4A SG142127A1 (en) 2003-09-12 2003-09-12 Vapor fraction from seeds of glycine max (l.) merr. and composition thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG200306386-4A SG142127A1 (en) 2003-09-12 2003-09-12 Vapor fraction from seeds of glycine max (l.) merr. and composition thereof

Publications (1)

Publication Number Publication Date
SG142127A1 true SG142127A1 (en) 2008-05-28

Family

ID=39426718

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200306386-4A SG142127A1 (en) 2003-09-12 2003-09-12 Vapor fraction from seeds of glycine max (l.) merr. and composition thereof

Country Status (1)

Country Link
SG (1) SG142127A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130072577A1 (en) * 2009-08-17 2013-03-21 Alexander ChinHak Chong Vaporized Medicants and Methods of Use
US9770408B2 (en) 2009-08-17 2017-09-26 Chong Corporation Vaporized medicants and methods of use
US10098918B2 (en) 2009-08-17 2018-10-16 Chong Corporation Vaporized medicants and methods of use
US10758582B2 (en) 2009-08-17 2020-09-01 Xten Capital Group, Inc. Vaporized medicants and methods of use
US10918684B2 (en) 2009-08-17 2021-02-16 Cqens Technologies, Inc. Vaporized medicants and methods of use

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61275224A (en) * 1985-05-29 1986-12-05 Sunstar Inc Collagenase-inhibiting agent
JPH0925225A (en) * 1995-05-09 1997-01-28 Sansho Seiyaku Co Ltd Skin external agent and production of active component for the agent
JPH1029911A (en) * 1996-07-16 1998-02-03 Osaka Yakuhin Kenkyusho:Kk Cosmetic material composition
JP2001151636A (en) * 1999-09-09 2001-06-05 Mitsuko Sawada Pack for cosmetic and production thereof
US6555118B1 (en) * 2001-02-22 2003-04-29 Sarfaraz K Niazi Pharmaceutical preparation for the treatment of topical wounds and ulcers

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61275224A (en) * 1985-05-29 1986-12-05 Sunstar Inc Collagenase-inhibiting agent
JPH0925225A (en) * 1995-05-09 1997-01-28 Sansho Seiyaku Co Ltd Skin external agent and production of active component for the agent
JPH1029911A (en) * 1996-07-16 1998-02-03 Osaka Yakuhin Kenkyusho:Kk Cosmetic material composition
JP2001151636A (en) * 1999-09-09 2001-06-05 Mitsuko Sawada Pack for cosmetic and production thereof
US6555118B1 (en) * 2001-02-22 2003-04-29 Sarfaraz K Niazi Pharmaceutical preparation for the treatment of topical wounds and ulcers

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130072577A1 (en) * 2009-08-17 2013-03-21 Alexander ChinHak Chong Vaporized Medicants and Methods of Use
US8962040B2 (en) * 2009-08-17 2015-02-24 Alexander ChinHak Chong Vaporized medicants and methods of use
US9283180B2 (en) 2009-08-17 2016-03-15 Chong Corporation Vaporized medicants and methods of use
US9770408B2 (en) 2009-08-17 2017-09-26 Chong Corporation Vaporized medicants and methods of use
US10098918B2 (en) 2009-08-17 2018-10-16 Chong Corporation Vaporized medicants and methods of use
US10610483B2 (en) 2009-08-17 2020-04-07 Chong Corporation Vaporized medicants and methods of use
US10758582B2 (en) 2009-08-17 2020-09-01 Xten Capital Group, Inc. Vaporized medicants and methods of use
US10918684B2 (en) 2009-08-17 2021-02-16 Cqens Technologies, Inc. Vaporized medicants and methods of use
US11622985B2 (en) 2009-08-17 2023-04-11 Cqens Technologies, Inc. Vaporized medicants and methods of use

Similar Documents

Publication Publication Date Title
MXPA05008617A (en) Uses of anti-insulin-like growth factor i receptor antibodies.
WO2005000245A3 (en) Compositions and methods for increasing telomerase activity
TW201129368A (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
WO2004069190A3 (en) Combination therapy for treating protein deficiency disorders
WO2005044179A3 (en) Formulations containing astragalus extracts and uses thereof
TW200637522A (en) Skin treatment articles and methods
WO2005000215A3 (en) Methods for treating pain
AU2003301190A1 (en) Administration of capsaicinoids
MXPA05006269A (en) Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration.
WO2005065269A3 (en) Compositions and method for decreasing the appearance of skin wrinkles
WO2005081742A3 (en) Testosterone oral dosage formulations and associated methods
EP1658853A4 (en) Remedy for internal administration against cranial nerve diseases containing mesenchymal cells as the active ingredient
WO2010085039A3 (en) Noggin-derived peptide and use thereof
TW200801031A (en) Steroid nitrooxyderivatives
WO2002064088A3 (en) Pharmaceutical composition for the treatment of alopecia
WO2012014081A8 (en) Use of a composition comprising a peptidic fava bean extract for the stimulation of hair growth
MXPA05010708A (en) Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases.
PT1414473E (en) ORAL ADMINISTRATION COMPOSITIONS FOR THE TREATMENT OF CABELUDE LEATHER DISTURBLES
TW200724150A (en) Plant extracts for treating skin disorders and enhancing healing of wounds for diabetics patients
SG142127A1 (en) Vapor fraction from seeds of glycine max (l.) merr. and composition thereof
CN105362105A (en) Mask with effects of skin metabolism improving and aging delaying, and preparation method thereof
TW200505466A (en) Vapor fraction from seeds of glycine max (l.) merr. and composition thereof
DE60310742D1 (en) EXTRACT WITH ANTITUMORAL AND ANTITOXIC EFFECT
WO2005009456A3 (en) Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment
MY148508A (en) Vapor fraction from seeds of glycine max (l.) merr. and compositions thereof